US Business

The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug results look more promising.

The owner of Silicon Valley’s Done Global was arrested, but the telehealth company’s staff in China still provides easy access to stimulants for Americans.

A trial in the case was set to begin Sept. 30, while Smartmatic has a separate suit pending against Fox News.

Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.

The e-commerce giant is one of the biggest U.S. employers to respond to government pressure to make overdose medicine more available in the workplace.

News Corp-controlled REA Group has made a fourth proposal to buy British peer Rightmove for roughly $8.3 billion in cash and shares, and urged its board to enter into talks.

The impact is, at best, indirect and uncertain, a finance professor argues. But there are better ways to accomplish what advocates are seeking.

The National Transportation Safety Board issued urgent recommendations for about 350 Boeing 737 jets globally.

Ireland’s data protection watchdog fined Meta Platforms after the Facebook and Instagram owner stored passwords of some social media users on its internal systems without proper safeguards.

Nike’s new leader started at the bottom of his company and made it to the very top. That might just be his biggest edge.